Therapeutic activity of chlorhexidine-poloxamer antiseptic gel on wound healing in rats: a preclinical study.

Despite the progress in curative and preventive medicine, skin lesions after injuries or surgical interventions are still a big problem. The aim of wound care is to get damaged tissues to heal as soon as possible. A gel-forming material helps to maintain proper humidity in the wound and promotes the healing process. For this purpose, a healing gel containing the active substance chlorhexidine based on poloxamer was prepared. The aim of this study was to assess in vivo the therapeutic efficacy of chlorhexidine-poloxamer gel in treatment of wounds caused experimentally and inoculated with bacteria, and the effect of an antiseptic gel applied on a healthy rat skin. Wistar albino rats were selected for these studies. The effect of an antiseptic gel on the healing excision and incision wounds, as well as the irritating effect on the healthy skin were assessed. Cross-sectional full-thickness specimens from each group were collected at the end of the experiment to assess the histopathological alterations. Chlorhexidine-poloxamer gels accelerate the healing of infected skin wounds because the active ingredient chlorhexidine remains at the application site, and systemic effects are avoided. Moreover, chlorhexidine-poloxamer gels are easy to use because they can be easily washed off from the wound surface by water. The present study has revealed that chlorhexidine-poloxamer gels promote healing of full-thickness skin wounds without skin irritation. This makes it possible to plan further clinical trials in the target species.

Influence of novel intravenous complex solution of Ca, Mg and phosphates on blood biochemical parameters of healthy and paretic cows.

The article describes the dynamics of changes in blood concentrations of the active substances present in the solution after its infusion to healthy cows in comparison to NaCI solution as well as the response of paretic cows to treatment with the new complex solution. Cows received a dose of 400 ml of A1 solution (containing 8.4 g of Ca2+) intravenously. In healthy cows the average calcium concentration in blood serum prior to the test was 2.52 +/- 0.08 mmol/l while 15 min. after the infusion the concentration rose to 3.10 +/- 0.08 mmol/l (p < 0.05) and magnesium concentration rose from 0.61 +/- 0.05 to 1.39 +/- 0.08 mmol/l (p < 0.05). This experiment showed that elevated concentration of non-organic phosphates persisted 1 hour after infusion (p < 0.05). In the second phase of efficacy evaluation of the novel preparation A1 on paretic cows the intravenous injection of 1 ml/kg of body weight of A1 solution increased calcium concentration up to almost normal level (p < 0.05). The level of magnesium in serum 1 h after injection was statistically significantly higher by 63% (p < 0.05) and reached the physiologically normal concentration. 1 h after the infusion of test solution the level of phosphate was higher by 13% (p > 0.05). The rise was statistically not significant. Even though A1 solution undoubtedly produced an increase in glucose concentration in the blood serum, due to wide dispersion of individual measurements and high standard deviation the increase (p > 0.05) in glucose concentration was found insignificant. Most of the treated paretic cows rose within 1-6 h after infusion of 400 ml of solution A1. No relapses were observed. A combination of different salts of calcium and magnesium, non-organic phosphates and glucose with analeptic substance mixed in one solution (A1 solution) administered at a dose of 1 ml/kg of body weight raises concentrations of essential macroelements in blood serum of cattle and promotes improvement of paretic cows condition.

Trends in monitoring residues of pharmacologically active group B substances in products of animal origin in Lithuania from 1999 to 2008.

Monitoring data of group B pharmacologically active substances in the Republic of Lithuania during the period 1999-2008 are presented. Peer review is based on data taken from residue-monitoring plans of the years 1999-2008 and the National Food and Veterinary Risk Assessment Institute reports on analyses performed in various foods. The data were analysed with the SPSS statistical package. Analysis of group B pharmacologically active substances residues monitoring results from the years 1999-2008 revealed that 25,030 samples were tested to detect 421 (1.68%) non-compliant samples in three groups of substances: antibacterials, anthelmintics and non-steroidal anti-inflammatory drugs. Most residues (88.3%) were found in milk, and were far less in beef, pork, sheep and goat meat.